Casella Process Solutions

Executive Summary

Casella Process Solutions is a privately-held biopharmaceutical services company headquartered in Boston, MA, founded in 2015. The company specializes in process development and manufacturing solutions for biologics and drug delivery technologies, serving biopharma clients from early development through commercial production. With a focus on enabling therapeutic candidates, Casella positions itself as a key partner in the biologics supply chain. While the company operates in a competitive CDMO market, its Boston location and specialization in drug delivery may offer differentiation. However, limited public information on financials, client base, or operational scale constrains a full assessment. Casella's growth prospects hinge on expanding capacity, securing strategic partnerships, and capitalizing on the growing biologics outsourcing trend.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new facility expansion or capacity addition70% success
• Q3 2026Major partnership or contract win with a top pharma or biotech50% success
• TBDLaunch of new service offering (e.g., mRNA or cell therapy manufacturing)40% success